1 / 6

Where Should eHARS be Headed?

Where Should eHARS be Headed?. Benjamin T. Laffoon. Epidemiologist 2012 CSTE Annual Conference June 3, 2012. National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention. Division of HIV/AIDS Prevention. Questions to Guide Discussion. What are key features of eHARS that you like?

millie
Download Presentation

Where Should eHARS be Headed?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Where Should eHARS be Headed? Benjamin T. Laffoon Epidemiologist 2012 CSTE Annual Conference June 3, 2012 National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention

  2. Questions to Guide Discussion • What are key features of eHARS that you like? • What functions, reports, algorithms, etc. are most used and would be missed if changed?

  3. Questions to Guide Discussion • What are some functions that are not in eHARS that you need? • What functions, reports, algorithms, etc. are not in eHARS that, if included, would make it better?

  4. Questions to Guide Discussion • What key functions do other data systems offer that eHARS does not?

  5. Questions to Guide Discussion • Could the use of a locally executed analysis program replace the need for a person view summary? • How important is the PV summary to your daily work? • Who uses the PV most often, data entry staff or data analysts? • Is the PV summary used for real-time QA efforts in your jurisdiction?

  6. Questions to Guide Discussion • How would the potential use of a fully integrated surveillance database (including STD, Hepatitis, HIV, and TB) affect your HIV surveillance program? • What are the key benefits? • What are the key barriers? • Can this reasonably be done given the document based surveillance model compared to the case or event based systems used for other diseases?

More Related